MIM
TIL icon

MetLife Investment Management’s Instil Bio TIL Stock Holding History

MetLife Investment Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,167
Closed -$210K – 2844
2022
Q3 		$210K Buy
2,167
+581
+37% +$66.5K ﹤0.01% 2263
2022
Q2 		$147K Hold
1,586
– – ﹤0.01% 2511
2022
Q1 		$341K Buy
1,586
+565
+55% +$132K ﹤0.01% 2021
2021
Q4 		$349K Buy
1,021
+601
+143% +$232K ﹤0.01% 1705
2021
Q3 		$150K Hold
420
– – ﹤0.01% 2257
2021
Q2 		$162K Buy
+420
New +$156K ﹤0.01% 2281

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MetLife Investment Management's TIL Position: Q4 2022 in Review

MetLife Investment Management sold out of Instil Bio (TIL) in Q4 2022, closing a stake of 2,167 shares — an estimated $210K sold.

MetLife Investment Management first reported a position in TIL in Q2 2021 and held it in 6 quarters. The position peaked at $349K in Q4 2021. 78 funds tracked by Wall St. Rank hold TIL as of Q4 2022.

  • MetLife Investment Management reported no remaining Instil Bio position as of Q4 2022 after selling out during the quarter.
  • MetLife Investment Management sold 2,167 Instil Bio shares in Q4 2022, an estimated $210K.
  • MetLife Investment Management first reported a position in Instil Bio in Q2 2021 and held it in 6 quarters.
  • MetLife Investment Management's Instil Bio position peaked at $349K in Q4 2021.
  • 78 funds tracked by Wall St. Rank held Instil Bio as of Q4 2022.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.